Molecular and in silico analysis of BRCA1 and BRCA2 variants

Stefania Tommasi, Brunella Pilato, Rosamaria Pinto, Alessandro Monaco, Michele Bruno, Marco Campana, Maria Digennaro, Francesco Schittulli, Rosanna Lacalamita, Angelo Paradiso

Research output: Contribution to journalArticle

Abstract

Germline mutations of high penetrant BRCA1 and BRCA2 genes have been associated to hereditary breast cancer risk, while polymorphic variants of the two genes still have an unknown role in breast pathogenesis. The aim of our study was to characterize BRCA1 and BRCA2 genes polymorphic variants in familial breast cancer. 110 patients affected by familial breast and/or ovarian cancer have been consecutively enrolled according to family history and BRCA mutation risk. All of them have been screened for BRCA1 and BRCA2 pathogenetic mutations, SNPs and intronic variants. In silico analysis have been also performed using different computational methods to individualize genetic variations that can alter the two genes expression and function. BRCA1 resulted mutated in 14% while BRCA2 in 3% of cases, while 80% of patients presented at least one polymorphism. A neural network splicing prediction model individualized one BRCA1 and one BRCA2 intronic variants able to determine alternative splicing. Furthermore, Q356R BRCA1 and N289H BRCA2 appear to show a possible harmful role also due to their location in functional regions of the two genes. However, in silico data are not always consistent with biological evidences. In conclusion, SNPs profile provides a basis for DNA-based cancer risk classification and help to define the gene alterations that could influence biochemistry activity protein or could modify drug sensitivity.

Original languageEnglish
Pages (from-to)64-70
Number of pages7
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume644
Issue number1-2
DOIs
Publication statusPublished - Sep 26 2008

Fingerprint

BRCA2 Gene
Computer Simulation
BRCA1 Gene
Single Nucleotide Polymorphism
Genes
Mutation
Germ-Line Mutation
Alternative Splicing
Biochemistry
Ovarian Neoplasms
Breast
Breast Neoplasms
Gene Expression
DNA
Pharmaceutical Preparations
Neoplasms
Proteins
Familial Breast Cancer

Keywords

  • BRCA
  • Breast cancer risk
  • Familiarity
  • In silico analysis
  • Mutation
  • Polymorphisms

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Molecular and in silico analysis of BRCA1 and BRCA2 variants. / Tommasi, Stefania; Pilato, Brunella; Pinto, Rosamaria; Monaco, Alessandro; Bruno, Michele; Campana, Marco; Digennaro, Maria; Schittulli, Francesco; Lacalamita, Rosanna; Paradiso, Angelo.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 644, No. 1-2, 26.09.2008, p. 64-70.

Research output: Contribution to journalArticle

Tommasi, Stefania ; Pilato, Brunella ; Pinto, Rosamaria ; Monaco, Alessandro ; Bruno, Michele ; Campana, Marco ; Digennaro, Maria ; Schittulli, Francesco ; Lacalamita, Rosanna ; Paradiso, Angelo. / Molecular and in silico analysis of BRCA1 and BRCA2 variants. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2008 ; Vol. 644, No. 1-2. pp. 64-70.
@article{e59c292010f646ecb613d0ecfe14fc56,
title = "Molecular and in silico analysis of BRCA1 and BRCA2 variants",
abstract = "Germline mutations of high penetrant BRCA1 and BRCA2 genes have been associated to hereditary breast cancer risk, while polymorphic variants of the two genes still have an unknown role in breast pathogenesis. The aim of our study was to characterize BRCA1 and BRCA2 genes polymorphic variants in familial breast cancer. 110 patients affected by familial breast and/or ovarian cancer have been consecutively enrolled according to family history and BRCA mutation risk. All of them have been screened for BRCA1 and BRCA2 pathogenetic mutations, SNPs and intronic variants. In silico analysis have been also performed using different computational methods to individualize genetic variations that can alter the two genes expression and function. BRCA1 resulted mutated in 14{\%} while BRCA2 in 3{\%} of cases, while 80{\%} of patients presented at least one polymorphism. A neural network splicing prediction model individualized one BRCA1 and one BRCA2 intronic variants able to determine alternative splicing. Furthermore, Q356R BRCA1 and N289H BRCA2 appear to show a possible harmful role also due to their location in functional regions of the two genes. However, in silico data are not always consistent with biological evidences. In conclusion, SNPs profile provides a basis for DNA-based cancer risk classification and help to define the gene alterations that could influence biochemistry activity protein or could modify drug sensitivity.",
keywords = "BRCA, Breast cancer risk, Familiarity, In silico analysis, Mutation, Polymorphisms",
author = "Stefania Tommasi and Brunella Pilato and Rosamaria Pinto and Alessandro Monaco and Michele Bruno and Marco Campana and Maria Digennaro and Francesco Schittulli and Rosanna Lacalamita and Angelo Paradiso",
year = "2008",
month = "9",
day = "26",
doi = "10.1016/j.mrfmmm.2008.07.005",
language = "English",
volume = "644",
pages = "64--70",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Molecular and in silico analysis of BRCA1 and BRCA2 variants

AU - Tommasi, Stefania

AU - Pilato, Brunella

AU - Pinto, Rosamaria

AU - Monaco, Alessandro

AU - Bruno, Michele

AU - Campana, Marco

AU - Digennaro, Maria

AU - Schittulli, Francesco

AU - Lacalamita, Rosanna

AU - Paradiso, Angelo

PY - 2008/9/26

Y1 - 2008/9/26

N2 - Germline mutations of high penetrant BRCA1 and BRCA2 genes have been associated to hereditary breast cancer risk, while polymorphic variants of the two genes still have an unknown role in breast pathogenesis. The aim of our study was to characterize BRCA1 and BRCA2 genes polymorphic variants in familial breast cancer. 110 patients affected by familial breast and/or ovarian cancer have been consecutively enrolled according to family history and BRCA mutation risk. All of them have been screened for BRCA1 and BRCA2 pathogenetic mutations, SNPs and intronic variants. In silico analysis have been also performed using different computational methods to individualize genetic variations that can alter the two genes expression and function. BRCA1 resulted mutated in 14% while BRCA2 in 3% of cases, while 80% of patients presented at least one polymorphism. A neural network splicing prediction model individualized one BRCA1 and one BRCA2 intronic variants able to determine alternative splicing. Furthermore, Q356R BRCA1 and N289H BRCA2 appear to show a possible harmful role also due to their location in functional regions of the two genes. However, in silico data are not always consistent with biological evidences. In conclusion, SNPs profile provides a basis for DNA-based cancer risk classification and help to define the gene alterations that could influence biochemistry activity protein or could modify drug sensitivity.

AB - Germline mutations of high penetrant BRCA1 and BRCA2 genes have been associated to hereditary breast cancer risk, while polymorphic variants of the two genes still have an unknown role in breast pathogenesis. The aim of our study was to characterize BRCA1 and BRCA2 genes polymorphic variants in familial breast cancer. 110 patients affected by familial breast and/or ovarian cancer have been consecutively enrolled according to family history and BRCA mutation risk. All of them have been screened for BRCA1 and BRCA2 pathogenetic mutations, SNPs and intronic variants. In silico analysis have been also performed using different computational methods to individualize genetic variations that can alter the two genes expression and function. BRCA1 resulted mutated in 14% while BRCA2 in 3% of cases, while 80% of patients presented at least one polymorphism. A neural network splicing prediction model individualized one BRCA1 and one BRCA2 intronic variants able to determine alternative splicing. Furthermore, Q356R BRCA1 and N289H BRCA2 appear to show a possible harmful role also due to their location in functional regions of the two genes. However, in silico data are not always consistent with biological evidences. In conclusion, SNPs profile provides a basis for DNA-based cancer risk classification and help to define the gene alterations that could influence biochemistry activity protein or could modify drug sensitivity.

KW - BRCA

KW - Breast cancer risk

KW - Familiarity

KW - In silico analysis

KW - Mutation

KW - Polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=49749090418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749090418&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2008.07.005

DO - 10.1016/j.mrfmmm.2008.07.005

M3 - Article

C2 - 18694767

AN - SCOPUS:49749090418

VL - 644

SP - 64

EP - 70

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -